Reducing Opioid Mortality in Illinois

Launched by UNIVERSITY OF CHICAGO · Jun 4, 2021

Keywords

ClinConnect Summary

The "Reducing Opioid Mortality in Illinois" (ROMI) trial is a five-year research study aimed at finding better ways to connect people who have a history of opioid use disorder with treatment after they are released from jails and prisons in Illinois. This study is being conducted by the University of Chicago along with other partners and is part of a larger effort by the National Institutes of Health to improve addiction treatment in criminal justice settings across the country. By understanding how to effectively link these individuals to support services, the goal is to reduce the number of deaths related to opioid use.

To be eligible for this study, participants must be at least 18 years old and live in specific areas designated for the research. They should also have a history of using opioids in a way that could indicate opioid use disorder, which includes misusing prescription opioids or using heroin. However, individuals with cognitive impairments that prevent them from giving informed consent or those who live outside the service area cannot participate. If you join the study, you can expect to be part of important research that aims to provide better treatment options for people struggling with opioid addiction.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants must be at least 18 years old
• • Reside in designated research site county or zip code
• • Satisfy criteria for likely OUD based upon nonmedical use of prescription opioids, heroin, or synthetic opioids.
• Exclusion Criteria:
• • Participants experiencing cognitive impairments that preclude informed consent.
• • Reside out of the service area.
• • Prior enrollment in a parallel JCOIN study.